Healio: Glecaprevir/pibrentasvir highly effective for treating HCV genotype 1

Glecaprevir/pibrentasvir was highly effective and well tolerated for the treatment of hepatitis C virus genotype 1 infection in patients who previously failed treatment with direct-acting antivirals, according to the results of the phase 2 open-label MAGELLAN-1 study.

Read the full story at Healio



Share This Article!
Article Categories: In the News